Loading…

Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion

The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes & metabolic syndrome clinical research & reviews 2021-01, Vol.15 (1), p.55-62
Main Authors: Das, Ashok Kumar, Kalra, Sanjay, B, Krishnakumar, Sharma, Kamal, John, Mathew, Nair, Tiny, Shaikh, Shehla, Khandelwal, Deepak, Priya, Gagan, Dutta, Deep, Gangadhar, Prathosh, Dhingra, Atul, Tiwaskar, Mangesh, Shukla, Rishi, Das, Sambit, Baruah, Manash Pratim, Gangopadhyay, Kalyan Kumar, Ramakrishnan, Santosh, Deshmukh, Vaishali, Dasgupta, Arundhati, Kumar, GVijaya, Pandey, Neelam, Joshi, Amya, Surana, Vineet Kumar, Punyani, Hitesh, Shah, Parag, Rattan, Aditya, Chandrasekaran, Sruti, Asirwatham, Arthur
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413
container_end_page 62
container_issue 1
container_start_page 55
container_title Diabetes & metabolic syndrome clinical research & reviews
container_volume 15
creator Das, Ashok Kumar
Kalra, Sanjay
B, Krishnakumar
Sharma, Kamal
John, Mathew
Nair, Tiny
Shaikh, Shehla
Khandelwal, Deepak
Priya, Gagan
Dutta, Deep
Gangadhar, Prathosh
Dhingra, Atul
Tiwaskar, Mangesh
Shukla, Rishi
Das, Sambit
Baruah, Manash Pratim
Gangopadhyay, Kalyan Kumar
Ramakrishnan, Santosh
Deshmukh, Vaishali
Dasgupta, Arundhati
Kumar, GVijaya
Pandey, Neelam
Joshi, Amya
Surana, Vineet Kumar
Punyani, Hitesh
Shah, Parag
Rattan, Aditya
Chandrasekaran, Sruti
Asirwatham, Arthur
description The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints. The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion. The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic. The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic. •Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
doi_str_mv 10.1016/j.dsx.2020.11.014
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7677048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1871402120304793</els_id><sourcerecordid>2470026934</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EoqXwAbggH7lksWMnTkBCQuFfpUq9AFdrYk92vXLiYCer9sonx8u2FVw42Z73m-fRPEJecrbhjNdv9hubbjYlK_ObbxiXj8g5b1RTMCHk4z93XkhW8jPyLKU9Y1XVlu1TciaEyAZKnZNfHUTrwogL9ME7Qw9u6zxMBqmbaHf94_JjwVsKk6URU1hjFnZr6nMh3h6R-2phduA9Tlu0dHEjpre0825yBjydI5jFZYb2kLKONzPGhYY562F6Tp4M4BO-uDsvyPfPn751X4ur6y-X3YerwkgmlgJBMTb0aFVbDVApQCVVLwCBARPY28a2NXJrSgMGRYVDbZtBtEMPyCvJxQV5f_Kd135Ea3BaIng9RzdCvNUBnP5XmdxOb8NBq1opJpts8PrOIIafK6ZFjy4Z9HldGNakS5knLOtWyIzyE2piSCni8PANZ_qYnd7rnJ0-Zqc51zm73PPq7_keOu7DysC7E4B5SweHUSfjMEdlXUSzaBvcf-x_A9XIro8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2470026934</pqid></control><display><type>article</type><title>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</title><source>Elsevier</source><creator>Das, Ashok Kumar ; Kalra, Sanjay ; B, Krishnakumar ; Sharma, Kamal ; John, Mathew ; Nair, Tiny ; Shaikh, Shehla ; Khandelwal, Deepak ; Priya, Gagan ; Dutta, Deep ; Gangadhar, Prathosh ; Dhingra, Atul ; Tiwaskar, Mangesh ; Shukla, Rishi ; Das, Sambit ; Baruah, Manash Pratim ; Gangopadhyay, Kalyan Kumar ; Ramakrishnan, Santosh ; Deshmukh, Vaishali ; Dasgupta, Arundhati ; Kumar, GVijaya ; Pandey, Neelam ; Joshi, Amya ; Surana, Vineet Kumar ; Punyani, Hitesh ; Shah, Parag ; Rattan, Aditya ; Chandrasekaran, Sruti ; Asirwatham, Arthur</creator><creatorcontrib>Das, Ashok Kumar ; Kalra, Sanjay ; B, Krishnakumar ; Sharma, Kamal ; John, Mathew ; Nair, Tiny ; Shaikh, Shehla ; Khandelwal, Deepak ; Priya, Gagan ; Dutta, Deep ; Gangadhar, Prathosh ; Dhingra, Atul ; Tiwaskar, Mangesh ; Shukla, Rishi ; Das, Sambit ; Baruah, Manash Pratim ; Gangopadhyay, Kalyan Kumar ; Ramakrishnan, Santosh ; Deshmukh, Vaishali ; Dasgupta, Arundhati ; Kumar, GVijaya ; Pandey, Neelam ; Joshi, Amya ; Surana, Vineet Kumar ; Punyani, Hitesh ; Shah, Parag ; Rattan, Aditya ; Chandrasekaran, Sruti ; Asirwatham, Arthur</creatorcontrib><description>The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints. The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion. The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic. The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic. •Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.</description><identifier>ISSN: 1871-4021</identifier><identifier>ISSN: 1878-0334</identifier><identifier>EISSN: 1878-0334</identifier><identifier>DOI: 10.1016/j.dsx.2020.11.014</identifier><identifier>PMID: 33310177</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Blood Glucose - drug effects ; Blood Glucose - metabolism ; Cardiometabolic vigilance ; Cardiotonic Agents - therapeutic use ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - epidemiology ; COVID-19 - diagnosis ; COVID-19 - epidemiology ; COVID-19 - prevention &amp; control ; COVID-19 resource husbandry ; Diabetes mellitus ; Health Resources - trends ; Humans ; Hypertension ; Hypertension - diagnosis ; Hypertension - drug therapy ; Hypertension - epidemiology ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; India - epidemiology ; Metabolic Diseases - diagnosis ; Metabolic Diseases - drug therapy ; Metabolic Diseases - epidemiology</subject><ispartof>Diabetes &amp; metabolic syndrome clinical research &amp; reviews, 2021-01, Vol.15 (1), p.55-62</ispartof><rights>2020 Diabetes India</rights><rights>Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.</rights><rights>2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2020 Diabetes India</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413</cites><orcidid>0000-0002-2696-1534 ; 0000-0002-6435-7995 ; 0000-0003-4915-8805 ; 0000-0002-3193-977X ; 0000-0001-5983-0453</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33310177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Das, Ashok Kumar</creatorcontrib><creatorcontrib>Kalra, Sanjay</creatorcontrib><creatorcontrib>B, Krishnakumar</creatorcontrib><creatorcontrib>Sharma, Kamal</creatorcontrib><creatorcontrib>John, Mathew</creatorcontrib><creatorcontrib>Nair, Tiny</creatorcontrib><creatorcontrib>Shaikh, Shehla</creatorcontrib><creatorcontrib>Khandelwal, Deepak</creatorcontrib><creatorcontrib>Priya, Gagan</creatorcontrib><creatorcontrib>Dutta, Deep</creatorcontrib><creatorcontrib>Gangadhar, Prathosh</creatorcontrib><creatorcontrib>Dhingra, Atul</creatorcontrib><creatorcontrib>Tiwaskar, Mangesh</creatorcontrib><creatorcontrib>Shukla, Rishi</creatorcontrib><creatorcontrib>Das, Sambit</creatorcontrib><creatorcontrib>Baruah, Manash Pratim</creatorcontrib><creatorcontrib>Gangopadhyay, Kalyan Kumar</creatorcontrib><creatorcontrib>Ramakrishnan, Santosh</creatorcontrib><creatorcontrib>Deshmukh, Vaishali</creatorcontrib><creatorcontrib>Dasgupta, Arundhati</creatorcontrib><creatorcontrib>Kumar, GVijaya</creatorcontrib><creatorcontrib>Pandey, Neelam</creatorcontrib><creatorcontrib>Joshi, Amya</creatorcontrib><creatorcontrib>Surana, Vineet Kumar</creatorcontrib><creatorcontrib>Punyani, Hitesh</creatorcontrib><creatorcontrib>Shah, Parag</creatorcontrib><creatorcontrib>Rattan, Aditya</creatorcontrib><creatorcontrib>Chandrasekaran, Sruti</creatorcontrib><creatorcontrib>Asirwatham, Arthur</creatorcontrib><title>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</title><title>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</title><addtitle>Diabetes Metab Syndr</addtitle><description>The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints. The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion. The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic. The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic. •Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.</description><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Cardiometabolic vigilance</subject><subject>Cardiotonic Agents - therapeutic use</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - drug therapy</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 resource husbandry</subject><subject>Diabetes mellitus</subject><subject>Health Resources - trends</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>India - epidemiology</subject><subject>Metabolic Diseases - diagnosis</subject><subject>Metabolic Diseases - drug therapy</subject><subject>Metabolic Diseases - epidemiology</subject><issn>1871-4021</issn><issn>1878-0334</issn><issn>1878-0334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAQxS0EoqXwAbggH7lksWMnTkBCQuFfpUq9AFdrYk92vXLiYCer9sonx8u2FVw42Z73m-fRPEJecrbhjNdv9hubbjYlK_ObbxiXj8g5b1RTMCHk4z93XkhW8jPyLKU9Y1XVlu1TciaEyAZKnZNfHUTrwogL9ME7Qw9u6zxMBqmbaHf94_JjwVsKk6URU1hjFnZr6nMh3h6R-2phduA9Tlu0dHEjpre0825yBjydI5jFZYb2kLKONzPGhYY562F6Tp4M4BO-uDsvyPfPn751X4ur6y-X3YerwkgmlgJBMTb0aFVbDVApQCVVLwCBARPY28a2NXJrSgMGRYVDbZtBtEMPyCvJxQV5f_Kd135Ea3BaIng9RzdCvNUBnP5XmdxOb8NBq1opJpts8PrOIIafK6ZFjy4Z9HldGNakS5knLOtWyIzyE2piSCni8PANZ_qYnd7rnJ0-Zqc51zm73PPq7_keOu7DysC7E4B5SweHUSfjMEdlXUSzaBvcf-x_A9XIro8</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Das, Ashok Kumar</creator><creator>Kalra, Sanjay</creator><creator>B, Krishnakumar</creator><creator>Sharma, Kamal</creator><creator>John, Mathew</creator><creator>Nair, Tiny</creator><creator>Shaikh, Shehla</creator><creator>Khandelwal, Deepak</creator><creator>Priya, Gagan</creator><creator>Dutta, Deep</creator><creator>Gangadhar, Prathosh</creator><creator>Dhingra, Atul</creator><creator>Tiwaskar, Mangesh</creator><creator>Shukla, Rishi</creator><creator>Das, Sambit</creator><creator>Baruah, Manash Pratim</creator><creator>Gangopadhyay, Kalyan Kumar</creator><creator>Ramakrishnan, Santosh</creator><creator>Deshmukh, Vaishali</creator><creator>Dasgupta, Arundhati</creator><creator>Kumar, GVijaya</creator><creator>Pandey, Neelam</creator><creator>Joshi, Amya</creator><creator>Surana, Vineet Kumar</creator><creator>Punyani, Hitesh</creator><creator>Shah, Parag</creator><creator>Rattan, Aditya</creator><creator>Chandrasekaran, Sruti</creator><creator>Asirwatham, Arthur</creator><general>Elsevier Ltd</general><general>Diabetes India. Published by Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2696-1534</orcidid><orcidid>https://orcid.org/0000-0002-6435-7995</orcidid><orcidid>https://orcid.org/0000-0003-4915-8805</orcidid><orcidid>https://orcid.org/0000-0002-3193-977X</orcidid><orcidid>https://orcid.org/0000-0001-5983-0453</orcidid></search><sort><creationdate>20210101</creationdate><title>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</title><author>Das, Ashok Kumar ; Kalra, Sanjay ; B, Krishnakumar ; Sharma, Kamal ; John, Mathew ; Nair, Tiny ; Shaikh, Shehla ; Khandelwal, Deepak ; Priya, Gagan ; Dutta, Deep ; Gangadhar, Prathosh ; Dhingra, Atul ; Tiwaskar, Mangesh ; Shukla, Rishi ; Das, Sambit ; Baruah, Manash Pratim ; Gangopadhyay, Kalyan Kumar ; Ramakrishnan, Santosh ; Deshmukh, Vaishali ; Dasgupta, Arundhati ; Kumar, GVijaya ; Pandey, Neelam ; Joshi, Amya ; Surana, Vineet Kumar ; Punyani, Hitesh ; Shah, Parag ; Rattan, Aditya ; Chandrasekaran, Sruti ; Asirwatham, Arthur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Cardiometabolic vigilance</topic><topic>Cardiotonic Agents - therapeutic use</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - drug therapy</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 resource husbandry</topic><topic>Diabetes mellitus</topic><topic>Health Resources - trends</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>India - epidemiology</topic><topic>Metabolic Diseases - diagnosis</topic><topic>Metabolic Diseases - drug therapy</topic><topic>Metabolic Diseases - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Das, Ashok Kumar</creatorcontrib><creatorcontrib>Kalra, Sanjay</creatorcontrib><creatorcontrib>B, Krishnakumar</creatorcontrib><creatorcontrib>Sharma, Kamal</creatorcontrib><creatorcontrib>John, Mathew</creatorcontrib><creatorcontrib>Nair, Tiny</creatorcontrib><creatorcontrib>Shaikh, Shehla</creatorcontrib><creatorcontrib>Khandelwal, Deepak</creatorcontrib><creatorcontrib>Priya, Gagan</creatorcontrib><creatorcontrib>Dutta, Deep</creatorcontrib><creatorcontrib>Gangadhar, Prathosh</creatorcontrib><creatorcontrib>Dhingra, Atul</creatorcontrib><creatorcontrib>Tiwaskar, Mangesh</creatorcontrib><creatorcontrib>Shukla, Rishi</creatorcontrib><creatorcontrib>Das, Sambit</creatorcontrib><creatorcontrib>Baruah, Manash Pratim</creatorcontrib><creatorcontrib>Gangopadhyay, Kalyan Kumar</creatorcontrib><creatorcontrib>Ramakrishnan, Santosh</creatorcontrib><creatorcontrib>Deshmukh, Vaishali</creatorcontrib><creatorcontrib>Dasgupta, Arundhati</creatorcontrib><creatorcontrib>Kumar, GVijaya</creatorcontrib><creatorcontrib>Pandey, Neelam</creatorcontrib><creatorcontrib>Joshi, Amya</creatorcontrib><creatorcontrib>Surana, Vineet Kumar</creatorcontrib><creatorcontrib>Punyani, Hitesh</creatorcontrib><creatorcontrib>Shah, Parag</creatorcontrib><creatorcontrib>Rattan, Aditya</creatorcontrib><creatorcontrib>Chandrasekaran, Sruti</creatorcontrib><creatorcontrib>Asirwatham, Arthur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Das, Ashok Kumar</au><au>Kalra, Sanjay</au><au>B, Krishnakumar</au><au>Sharma, Kamal</au><au>John, Mathew</au><au>Nair, Tiny</au><au>Shaikh, Shehla</au><au>Khandelwal, Deepak</au><au>Priya, Gagan</au><au>Dutta, Deep</au><au>Gangadhar, Prathosh</au><au>Dhingra, Atul</au><au>Tiwaskar, Mangesh</au><au>Shukla, Rishi</au><au>Das, Sambit</au><au>Baruah, Manash Pratim</au><au>Gangopadhyay, Kalyan Kumar</au><au>Ramakrishnan, Santosh</au><au>Deshmukh, Vaishali</au><au>Dasgupta, Arundhati</au><au>Kumar, GVijaya</au><au>Pandey, Neelam</au><au>Joshi, Amya</au><au>Surana, Vineet Kumar</au><au>Punyani, Hitesh</au><au>Shah, Parag</au><au>Rattan, Aditya</au><au>Chandrasekaran, Sruti</au><au>Asirwatham, Arthur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion</atitle><jtitle>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</jtitle><addtitle>Diabetes Metab Syndr</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>15</volume><issue>1</issue><spage>55</spage><epage>62</epage><pages>55-62</pages><issn>1871-4021</issn><issn>1878-0334</issn><eissn>1878-0334</eissn><abstract>The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment’s (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints. The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion. The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic. The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic. •Healthcare challenges during the pandemic are linked to resource constraints including shortage of PPE, laboratory tests and medications•A group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19•The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions•This will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33310177</pmid><doi>10.1016/j.dsx.2020.11.014</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2696-1534</orcidid><orcidid>https://orcid.org/0000-0002-6435-7995</orcidid><orcidid>https://orcid.org/0000-0003-4915-8805</orcidid><orcidid>https://orcid.org/0000-0002-3193-977X</orcidid><orcidid>https://orcid.org/0000-0001-5983-0453</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1871-4021
ispartof Diabetes & metabolic syndrome clinical research & reviews, 2021-01, Vol.15 (1), p.55-62
issn 1871-4021
1878-0334
1878-0334
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7677048
source Elsevier
subjects Blood Glucose - drug effects
Blood Glucose - metabolism
Cardiometabolic vigilance
Cardiotonic Agents - therapeutic use
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - epidemiology
COVID-19 - diagnosis
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 resource husbandry
Diabetes mellitus
Health Resources - trends
Humans
Hypertension
Hypertension - diagnosis
Hypertension - drug therapy
Hypertension - epidemiology
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
India - epidemiology
Metabolic Diseases - diagnosis
Metabolic Diseases - drug therapy
Metabolic Diseases - epidemiology
title Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A59%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiometabolic%20vigilance%20in%20COVID-19%20and%20resource%20husbandry%20in%20resource-challenged%20times:%20Clinical%20practice-%20based%20expert%20opinion&rft.jtitle=Diabetes%20&%20metabolic%20syndrome%20clinical%20research%20&%20reviews&rft.au=Das,%20Ashok%20Kumar&rft.date=2021-01-01&rft.volume=15&rft.issue=1&rft.spage=55&rft.epage=62&rft.pages=55-62&rft.issn=1871-4021&rft.eissn=1878-0334&rft_id=info:doi/10.1016/j.dsx.2020.11.014&rft_dat=%3Cproquest_pubme%3E2470026934%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c403t-ea700fbed795fa57ae747b3aea0a03ebd8d96e1dc2cace35ef6d8f39fbae15413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2470026934&rft_id=info:pmid/33310177&rfr_iscdi=true